Combining angioplasty with percutaneous microwave ablation for treating primary Budd-Chiari syndrome associated with hepatocellular carcinoma in two patients: A case report

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 612-616

  Zhang, Qing Qiao ^a   Zu, Mao Heng ^a   Xu, Hao ^a   Gu, Yu Ming ^a   Wang, Wen Liang ^a   Gao, Zhi Kang ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Angioplasty; Budd Chiari syndrome; Hepatocellular carcinoma; Percutaneous microwave ablation

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; IODINATED POPPYSEED OIL; PIRARUBICIN;

ADULT; ANGIOPLASTY; ARTERIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON DILATATION; BIOPSY; BLOOD CELL COUNT; BLOOD CLOT LYSIS; BUDD CHIARI SYNDROME; CASE REPORT; CATHETERIZATION; CELIAC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER FLOWMETRY; ECHOGRAPHY; FOLLOW UP; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERSPLENISM; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICROWAVE THERAPY; SPLENECTOMY; STENOSIS;

EID: 84879493084     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1417     Document Type: Article

References (20)

1. Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, HadengueA and Valla DC; European Group for the Study of Vascular Disorders of the Liver: Budd-Chiari syndrome: a review by an expert panel. J Hepatol 38: 364-371, 2003.
2. Rajani R, Melin T, Björnsson E, et al: Budd-Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival-an 18-year experience. Liver Int 29: 253-259, 2009.
3. Jang JW, Yoon SK, Bae SH, Choi JY, Chung KW and Sun HS: Rapidly progressing Budd-Chiari syndrome complicated by hepatocellular carcinoma. Korean J Intern Med 18: 191-195, 2003.
4. Moucari R, Rautou PE, Cazals-Hatem D, et al: Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors. Gut 57: 828-835, 2008.
5. Gwon D II, Ko GY, Yoon HK, et al: Hepatocellular carcinoma associated with membranous obstruction of the inferior vena cava: incidence, characteristics and risk factors and clinical efficacy of TACE. Radiology 254: 617-626, 2010.
6. Matsui S, Ichida T, Watanabe M, et al: Clinical features and etiology of hepatocellular carcinoma arising in patients with membranous obstruction of the inferior vena cava: in reference to hepatitis viral infection. J Gastroenterol Hepatol 15: 1205-1211, 2000.
7. Kage M: Budd-Chiari syndrome and hepatocellular carcinoma. JGastroenterol 39: 706-707, 2004.
8. Worns MA, Weinmann A, Pfingst K, et al: Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis. J Clin Gastroenterol 43: 489-495, 2009.
9. Xu K, Feng B, Zhong H, et al: Clinical application of interventional techniques in the treatment of Budd-Chiari syndrome. Chin Med J (Engl) 116: 609-615, 2003.
10. Chen CY, Li CW, Kuo YT, et al: Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants-initial experience. Radiology 239: 448-456, 2006.
11. Kew MC, McKnight A, Hodkinson J, Bukofzer S and Esser JD: The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African blacks. Hepatology 9: 121-125, 1989.
12. Orloff MJ, Isenberg JI, Wheeler HO, Daily PO and Girard B: Budd-Chiari syndrome revisited: 38 years' experience with surgical portal decompression. J Gastrointest Surg 16: 286-300, 2012.
13. Shrestha SM, Okuda K, Uchida T, et al: Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol 11: 170-179, 1996.
14. Shrestha SM: Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava. Hepatol Int 3: 392-402, 2009.
15. Brancatelli G, Federle MP, Grazioli L, Golfieri R and LencioniR: Benign regenerative nodules in Budd-Chiari syndrome and other vascular disorders of the liver: radiologic-pathologic and clinical correlation. Radiographics 22: 847-862, 2002.
16. Vilgrain V, Lewin M, Vons C, et al: Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology 210: 443-450, 1999.
17. Wu T, Wang L, Xiao Q, et al: Percutaneous balloon angioplasty of inferior vena cava in Budd-Chiari syndrome-R1. Int J Cardiol 83: 175-178, 2002.
18. Ding PX, Li YD, Han XW and Wu G: Agitation thrombolysis for fresh iatrogenic IVC thrombosis in patients with Budd-Chiari syndrome. J Vasc Surg 52: 782-784, 2010.
19. Bruix J, Hessheimer AJ, Forner A, Boix L, Vilana R and LlovetJM: New aspects of diagnosis and therapy of hepatocellular carcinoma. Oncogene 25: 3848-3856, 2006.
20. Liang P and Wang Y: Microwave ablation of hepatocellular carcinoma. Oncology 72 Suppl 1: 124-131, 2007.